Difference between revisions of "Rudnicki 2014 United States Patent Application Publication"
From Bioblast
Line 1: | Line 1: | ||
{{Publication | {{Publication | ||
|title=Rudnicki MA, Yin Hang (2014) MICRORNA INHIBITORS. United States Patent Application Publication 1-49. | |title=Rudnicki MA, Yin Hang (2014) MICRORNA INHIBITORS. United States Patent Application Publication 1-49. | ||
|info=[http://patents.justia.com/patent/20140221466 | |info=[http://patents.justia.com/patent/20140221466 Open access] | ||
|authors=Rudnicki MA, Yin Hang | |authors=Rudnicki MA, Yin Hang | ||
|year=2014 | |year=2014 | ||
|journal=United States Patent Application Publication | |journal=United States Patent Application Publication | ||
|abstract=The present invention relates to microRNAs (miRNAs) that are associated with obesity. The present invention is directed to methods, compounds, and compositions for preventing and treating obesity, as well as related diseases, using a microRNA inhibitor. | |abstract=The present invention relates to microRNAs (miRNAs) that are associated with obesity. The present invention is directed to methods, compounds, and compositions for preventing and treating obesity, as well as related diseases, using a microRNA inhibitor. | ||
|keywords=Patent | |||
}} | }} | ||
{{Labeling | {{Labeling | ||
|area=Respiration, Patients | |area=Respiration, Patients | ||
|organism= | |organism=Mouse | ||
|tissues=Skeletal muscle | |tissues=Skeletal muscle, Fat | ||
|preparations=Intact cells, Permeabilized cells | |preparations=Intact cells, Permeabilized cells | ||
|diseases=Obesity | |diseases=Obesity | ||
|couplingstates=LEAK, OXPHOS, ETS | |couplingstates=LEAK, ROUTINE, OXPHOS, ETS | ||
|substratestates=CI, CII, FAO, CI&II, ROX | |substratestates=CI, CII, FAO, CI&II, ROX | ||
|instruments=Oxygraph-2k | |instruments=Oxygraph-2k | ||
}} | }} |
Revision as of 10:14, 15 September 2016
Rudnicki MA, Yin Hang (2014) MICRORNA INHIBITORS. United States Patent Application Publication 1-49. |
Β» Open access
Rudnicki MA, Yin Hang (2014) United States Patent Application Publication
Abstract: The present invention relates to microRNAs (miRNAs) that are associated with obesity. The present invention is directed to methods, compounds, and compositions for preventing and treating obesity, as well as related diseases, using a microRNA inhibitor. β’ Keywords: Patent
Labels: MiParea: Respiration, Patients
Pathology: Obesity
Organism: Mouse Tissue;cell: Skeletal muscle, Fat Preparation: Intact cells, Permeabilized cells
Coupling state: LEAK, ROUTINE, OXPHOS, ETS"ETS" is not in the list (LEAK, ROUTINE, OXPHOS, ET) of allowed values for the "Coupling states" property.
HRR: Oxygraph-2k